Home
>
National Drug Code (NDC)
>
Azithromycin
Azithromycin - 0093-2026-31 - (Azithromycin)
Drug Information of Azithromycin
| Product NDC: | 0093-2026 |
| Proprietary Name: | Azithromycin |
| Non Proprietary Name: | Azithromycin |
| Active Ingredient(s): | 200 mg/5mL & nbsp; Azithromycin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Azithromycin
| Product NDC: | 0093-2026 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065246 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101217 |
Package Information of Azithromycin
| Package NDC: | 0093-2026-31 |
| Package Description: | 30 mL in 1 BOTTLE (0093-2026-31) |
NDC Information of Azithromycin
| NDC Code | 0093-2026-31 |
| Proprietary Name | Azithromycin |
| Package Description | 30 mL in 1 BOTTLE (0093-2026-31) |
| Product NDC | 0093-2026 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Azithromycin |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20101217 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | AZITHROMYCIN MONOHYDRATE |
| Strength Number | 200 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
